These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 37860559)

  • 1. Combinations of plasma cfDNA concentration, integrity and tumor markers are promising biomarkers for early diagnosis of non-small cell lung cancer.
    Ren S; Zeng G; Yi Y; Liu L; Tu H; Chai T; Hu L
    Heliyon; 2023 Oct; 9(10):e20851. PubMed ID: 37860559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma cell-free DNA level and its integrity as biomarkers to distinguish non-small cell lung cancer from tuberculosis.
    Leng S; Zheng J; Jin Y; Zhang H; Zhu Y; Wu J; Xu Y; Zhang P
    Clin Chim Acta; 2018 Feb; 477():160-165. PubMed ID: 29113814
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Value of the concentration and integrity of serum cell-free DNA for the clinical diagnosis of esophageal carcinoma].
    Qiu YW; Shen XJ; Jin CJ; Cao XJ; Ju SQ
    Zhonghua Zhong Liu Za Zhi; 2018 Dec; 40(12):905-910. PubMed ID: 30605980
    [No Abstract]   [Full Text] [Related]  

  • 4. Diagnostic value of combined detection of plasma cfDNA concentration and integrity in NSCLC.
    Ren S; Yu C; Huang Q
    Lung Cancer Manag; 2024; 13(1):LMT64. PubMed ID: 38812772
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluating circulating cell-free DNA and DNA integrity index as biomarkers in non-small cell lung cancer.
    Ezzeldin N; El-Lebedy D; Hassan M; Shalaby AO; Hussein SAM; Gharib AM; Hamdy G; Mohammed AM; Ramadan A; Sobeih ME
    J Egypt Natl Canc Inst; 2024 Jun; 36(1):21. PubMed ID: 38880832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of plasma cell-free DNA combined with VEGF-C in laryngeal squamous cell carcinoma.
    Huang Q; Ji M; Li F; Li Y; Zhou X; Hsueh CY; Zhou L
    Mol Cell Probes; 2023 Feb; 67():101895. PubMed ID: 36682577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A quantitative analysis of the potential biomarkers of non-small cell lung cancer by circulating cell-free DNA.
    Wei L; Wu W; Han L; Yu W; Du Y
    Oncol Lett; 2018 Oct; 16(4):4353-4360. PubMed ID: 30250538
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of serum cfDNA concentration and integrity before and after surgery in patients with lung cancer.
    Fan Y; Shi M; Chen S; Ju G; Chen L; Lu H; Chen J; Zheng S
    Cell Mol Biol (Noisy-le-grand); 2019 Jul; 65(6):56-63. PubMed ID: 31472048
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic Value of Circulating Free DNA Integrity and Global Methylation Status in Gall Bladder Carcinoma.
    Kumari S; Husain N; Agarwal A; Neyaz A; Gupta S; Chaturvedi A; Lohani M; Sonkar AA
    Pathol Oncol Res; 2019 Jul; 25(3):925-936. PubMed ID: 29376201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Circulating tumor DNA in Egyptian women with breast Cancer: A marker for detection of primary cases and early prediction of recurrence.
    Gameel AM; Talaat RM; Sakr MA; Selim MA; Abo Alil DFA; Elkhouly EA
    Clin Chim Acta; 2024 Aug; 562():119878. PubMed ID: 39047884
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Integrity and quantity of salivary cell-free DNA as a potential molecular biomarker in oral cancer: A preliminary study.
    Rapado-González Ó; López-Cedrún JL; Lago-Lestón RM; Abalo A; Rubin-Roger G; Salgado-Barreira Á; López-López R; Muinelo-Romay L; Suárez-Cunqueiro MM
    J Oral Pathol Med; 2022 May; 51(5):429-435. PubMed ID: 35416334
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasma cell-free DNA levels and integrity in patients with chest radiological findings: NSCLC versus benign lung nodules.
    Szpechcinski A; Rudzinski P; Kupis W; Langfort R; Orlowski T; Chorostowska-Wynimko J
    Cancer Lett; 2016 May; 374(2):202-7. PubMed ID: 26854716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating cell-free DNA variables as marker of ovarian cancer patients: A pilot study.
    Stamenkovic S; Cheng J; Surowy H; Burwinkel B; Gündert M
    Cancer Biomark; 2020; 28(2):159-167. PubMed ID: 32176629
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical significance of cell-free DNA concentration and integrity in serum of gastric cancer patients before and after surgery.
    Zhang X; Wu Z; Shen Q; Li R; Jiang X; Wu J; Li D; Wang D; Zou C; Zhong Y; Cheng X
    Cell Mol Biol (Noisy-le-grand); 2019 Sep; 65(7):111-117. PubMed ID: 31880527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Circulating Cell Free DNA Integrity Index as a Biomarker for Response to Chemotherapy in Patients with Metastatic Colorectal Carcinoma.
    Eskander NS; Mansour L; Abdelaal A; Saad E; Mohamed D
    Asian Pac J Cancer Prev; 2022 Jan; 23(1):339-348. PubMed ID: 35092403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of advanced non-small cell lung cancer patients by cfDNA analysis: experience from routine laboratory practice.
    González de Aledo-Castillo JM; Arcocha A; Victoria I; Martinez-Puchol AI; Sánchez C; Jares P; Rodríguez GF; Viñolas N; Reyes R; Reguart N; Puig-Butillé JA
    J Thorac Dis; 2021 Mar; 13(3):1658-1670. PubMed ID: 33841957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cell-free DNA levels in plasma of patients with non-small-cell lung cancer and inflammatory lung disease.
    Szpechcinski A; Chorostowska-Wynimko J; Struniawski R; Kupis W; Rudzinski P; Langfort R; Puscinska E; Bielen P; Sliwinski P; Orlowski T
    Br J Cancer; 2015 Jul; 113(3):476-83. PubMed ID: 26125447
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Urine cell-free DNA as a promising biomarker for early detection of non-small cell lung cancer.
    Ren S; Ren XD; Guo LF; Qu XM; Shang MY; Dai XT; Huang Q
    J Clin Lab Anal; 2020 Aug; 34(8):e23321. PubMed ID: 32281142
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical value of tumor-associated autoantibodies in diagnosis of early non-small cell lung cancer].
    Ren Z; Ding HM; Qian X; Pan SY
    Zhonghua Yu Fang Yi Xue Za Zhi; 2021 Dec; 55(12):1426-1434. PubMed ID: 34963239
    [No Abstract]   [Full Text] [Related]  

  • 20. Application of serum microRNA-9-5p, 21-5p, and 223-3p combined with tumor markers in the diagnosis of non-small-cell lung cancer in Yunnan in southwestern China.
    Yang Y; Chen K; Zhou Y; Hu Z; Chen S; Huang Y
    Onco Targets Ther; 2018; 11():587-597. PubMed ID: 29430184
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.